Evidence map›Paper›PMID 38540091›Full record

ArticleBiomedicines2024

Association of

Ivan Blazekovic, Ivan Samija, Josipa Perisa, Koraljka Gall Troselj, Tihana Regovic Dzombeta, Petra Radulovic, Matija Romic, Roko Granic, Ines Sisko Markos, Ana Frobe and 2 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Ivan BlazekovicDepartment of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, 10 000 Zagreb, Croatia.
Ivan SamijaDepartment of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, 10 000 Zagreb, Croatia.ORCID 0000-0002-5633-5745
Josipa PerisaDepartment of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, 10 000 Zagreb, Croatia.ORCID 0000-0002-1734-0015
Koraljka Gall TroseljLaboratory for Epigenomics, Division of Molecular Medicine, Ruđer Bošković Institute, 10 000 Zagreb, Croatia.ORCID 0000-0001-7501-7614
Tihana Regovic DzombetaDepartment of Pathology Ljudevit Jurak, University Hospital Center Sestre Milosrdnice, 10 000 Zagreb, Croatia.ORCID 0000-0002-8858-3524
Petra RadulovicDepartment of Pathology Ljudevit Jurak, University Hospital Center Sestre Milosrdnice, 10 000 Zagreb, Croatia.
Matija RomicDepartment of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, 10 000 Zagreb, Croatia.
Roko GranicDepartment of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, 10 000 Zagreb, Croatia.
Ines Sisko MarkosDepartment of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, 10 000 Zagreb, Croatia.ORCID 0000-0001-6425-0701
Ana FrobeDepartment of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, 10 000 Zagreb, Croatia.
Zvonko KusicCroatian Academy of Science and Arts, 10000 Zagreb, Croatia.
Tomislav JukicDepartment of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, 10 000 Zagreb, Croatia.
University Hospital Centre Zagreb · HRCroatian Academy of Sciences and Arts · HRRuđer Bošković Institute · HRSisters of Charity Hospital · HRUniversity of Zagreb · HR

Funding

Croatian Science Foundation IP-2019-04-1130
6 · The paper itself

Abstract

The early identification of aggressive forms of cancer is of high importance in treating papillary thyroid cancer (PTC). Disease dissemination is a major factor influencing patient survival. Mutation status of

Indexed as

BRAF V600Edisseminationpapillary thyroid cancerqPCRtumor heterogeneity

Identifiers

PMID38540091
PMCPMC10968519
OpenAlexW4392013704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.